Macleods Pharmaceuticals Ltd — Meloxicam Exporter Profile
Indian Pharmaceutical Exporter · #6 for Meloxicam · $850.0K export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #6 Indian exporter of Meloxicam with $850.0K in export value and 17 verified shipments. Macleods Pharmaceuticals Ltd holds a 0.5% market share in Meloxicam exports across 3 countries.
Macleods Pharmaceuticals Ltd — Meloxicam Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Meloxicam?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $213.8K | 25 | 73.7% |
| VIETNAM, DEMOCRATIC REP. OF | $50.0K | 1 | 17.2% |
| SRI LANKA | $18.0K | 1 | 6.2% |
| MYANMAR | $8.4K | 3 | 2.9% |
Macleods Pharmaceuticals Ltd exports Meloxicam to 4 countries. The largest destination is FRANCE accounting for 73.7% of Macleods Pharmaceuticals Ltd's Meloxicam shipments, followed by VIETNAM, DEMOCRATIC REP. OF (17.2%) and SRI LANKA (6.2%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Meloxicam from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PLANETPHARMA | FRANCE | $203.0K | 23 |
| CAMEL INTERNATIONAL IM -EXPORT CO, | VIETNAM, DEMOCRATIC REP. OF | $50.0K | 1 |
| STATE PHARMACEUTICALS CORP OF SRIL A | SRI LANKA | $18.0K | 1 |
| PLANETPHARMA ZAC DU GRAND LAUNAY | FRANCE | $10.8K | 2 |
| SWAN YEE SWAN HTET CO | MYANMAR | $7.8K | 1 |
| SIN PHYU KYUN COMPANY LIMITED | MYANMAR | $580 | 2 |
Macleods Pharmaceuticals Ltd supplies Meloxicam to 6 buyers globally. The largest buyer is PLANETPHARMA (FRANCE), followed by CAMEL INTERNATIONAL IM -EXPORT CO, (VIETNAM, DEMOCRATIC REP. OF) and STATE PHARMACEUTICALS CORP OF SRIL A (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Meloxicam Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $62.9M worth of Meloxicam through 3,297 shipments from 277 suppliers to 100 countries, serving 566 buyers globally. Macleods Pharmaceuticals Ltd contributes $850.0K to this total, accounting for 0.5% of India's Meloxicam exports. Macleods Pharmaceuticals Ltd ships Meloxicam to 4 countries through 6 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Meloxicam Exports?
Macleods Pharmaceuticals Ltd's average Meloxicam shipment value is $50.0K per consignment, based on 17 shipments totaling $850.0K. The largest destination is FRANCE (73.7% of Macleods Pharmaceuticals Ltd's Meloxicam exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Meloxicam Exporters?
Macleods Pharmaceuticals Ltd ranks #6 among 277 Indian Meloxicam exporters with a 0.5% market share. The top 3 exporters are CIPLA LIMITED ($28.7M), UNICHEM LABORATORIES LIMITED ($18.4M), ZYDUS LIFESCIENCES LIMITED ($6.2M). Macleods Pharmaceuticals Ltd processed 17 shipments to 3 destination countries.
What Meloxicam Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MELOCAM 15MG CPR B/50(MELOXICAM TABLETS | $97.0K | 4 |
| MELOCAM 7.5 (MELOXICAM TABLETS BP 7.5MG)10X10S (18397 PAC) | $50.0K | 1 |
| MELOCAM 7.5MG CPR B/50(MELOXICAM TABLETS | $47.4K | 4 |
| MELOCAM 15MG CPR B/50(MELOXICAM TABLETS 15 MG) 5X10 (3000 PAC) | $18.1K | 1 |
| MELOCAM 7.5MELOXICAM TABLETS 7.5MG 5X10S 54000 PAC | $18.0K | 1 |
| MELOCAM 7.5MG TABLETS(MELOXICAM TABLETS 7.5 MG) 5X10 (2980 PAC) | $11.7K | 1 |
| MELOCAM 15MG TABLETS(MELOXICAM TABLETS 15 MG) 5X10S (1719 PAC)TBS | $10.1K | 3 |
| MELOCAM 15MG CPR B/50MELOXICAM TABLETS15 MG 5X10S 1480 PAC | $8.9K | 1 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES MELOCAM 15 MELOXICAM TABLETS BP 15MG | $7.8K | 1 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES MELOCAM-7.5/Meloxicam Tablets BP 7.5mg | $7.7K | 1 |
Macleods Pharmaceuticals Ltd exports 18 distinct Meloxicam formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MELOCAM 15MG CPR B/50(MELOXICAM TABLETS with 4 shipments worth $97.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Meloxicam Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | GRACURE PHARMACEUTICALS LIMITED | $1.0M | 40 | 1 | $26.0K |
| 9 | CADILA HEALTHCARE LIMITED | $1.0M | 30 | 3 | $33.3K |
| 6 | MACLEODS PHARMACEUTICALS LTD ★ | $850.0K | 17 | 3 | $50.0K |
| 11 | STRIDES PHARMA SCIENCE LIMITED | $781.6K | 73 | 2 | $10.7K |
| 10 | ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED | $750.0K | 15 | 2 | $50.0K |
Macleods Pharmaceuticals Ltd ranks #6 among 277 Indian Meloxicam exporters. Average shipment value of $50.0K compared to the market average of $227.2K. The closest competitors by value are GRACURE PHARMACEUTICALS LIMITED and CADILA HEALTHCARE LIMITED.
Which Indian Ports Ship Meloxicam Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 583 | 17.7% |
| JNPT/ NHAVA SHEVA SEA | 374 | 11.3% |
| SAHAR AIR | 370 | 11.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 276 | 8.4% |
| JNPT | 242 | 7.3% |
| NHAVA SHEVA | 147 | 4.5% |
| MUNDRA SEA | 137 | 4.2% |
| Bombay Air | 117 | 3.5% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Meloxicam — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Meloxicam shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 30 individual customs records matching Macleods Pharmaceuticals Ltd exporting Meloxicam, covering 18 formulations to 4 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 566+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Meloxicam Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Meloxicam exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Meloxicam Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Meloxicam. For current shipment-level data, contact TransData Nexus.